A Brand New Network
Built by the mRNA community for the mRNA community
Membership allows you to plug into a forward-thinking, mRNA-specific network to promote pre-competitive knowledge sharing and value exchange, allowing us to avoid the duplication of work, capitalise on best practice and get better therapeutics and vaccines to patients faster
Utilise a diverse group of mRNA specialists with valuable experience to validate and improve your decision making
Overcome critical challenges and bottlenecks
Work as a collective to solve shared challenges, such as influencing the regulatory landscape to increase the likelihood, and speed of, new approvals
Save time and avoid
Find out what didn’t work as well as what did, through regular exchange of experiences and best practice
Current members from Life Science companies:
For more information on what is included as part of the mRNA-Based Therapeutics: Searchlight membership please download our membership brochure.
What will you learn?
- What's included in membership
- The member experiences
- The benefits of membership
- Who can you expect to be networking with?
- How to join the network
Our members say it best...
Jon Shanter, Director, Vaccine Process Development, Merck
“Regulatory opinions for mRNA will take time to stabilize but I’d expect the scope of this network to play an important role in accelerating that, which will mean getting better drugs to patients faster”
Theresa Goletz, Global Head Of Analytical Immunology & Cellular Platform, GSK
“This network offers us the valuable chance to discuss the things that don't appear in scientific publications as well as the chance to regularly engage with a trusted group of peers and see how the areas you’re interested in are evolving and advancing outside your company”
Ryan Shaler, Associate Director, Immunology & mRNA Discovery, Sonata Therapeutics
"It is so useful to have a sounding board of people doing the same work and facing the same challenges as us. Having a network like this will allow us to get answers faster than trying to muddle our way through it ourselves."
Who qualifies for mRNA-Based Therapeutics: Searchlight Network?
Expert mRNA leaders
Member companies are represented by one internal champion who has strategic oversight over its mRNA program
Motivated to collaborate
Success relies on the equitable exchange of experience and a focus on what can be shared rather than being restricted by what can’t
Experience to share
Members must be able to contribute to a series of overlapping shared challenges across the drug development lifecycle